CoreMap

Burlington, MA · Founded 2016 · Privately Held (backing)

Developer of a diagnostic technology designed to enable curative treatment options. CoreMap is based in Burlington, MA and was founded in 2016. Its last reported valuation was $67.3 million in Feb 2022. It has raised $44.1 million across 3 recorded rounds; the latest was a $35.5 million early-stage round in Jun 2026.

Last reported valuation
$67.3M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Early Stage VC
Jun 2026
How much has CoreMap raised?
$44.1Macross 3 recorded rounds · Jan 2022 – Jun 2026

Most recently, CoreMap raised $35.5M in its Early Stage VC (Jun 2026).

Free account
More of CoreMap with a free account
  • ·The complete investor list: 12 names
  • ·Watch CoreMap: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CoreMap round by round

3 rounds
Jun 2026Early Stage VC$35.5MSEC filing▮
73 investors participated
Jul 2024Early Stage VC$6.8MSEC filing▮
19 investors participated
Jan 2022Early Stage VC$23.2MSEC filing▮
26 investors participated

How much has CoreMap raised?

CoreMap has raised $44.1 million across 3 recorded rounds since 2022. The largest was a $6.8 million early-stage round in Jul 2024; the most recent was a $35.5 million early-stage round in Jun 2026.

CoreMap has filed 2 Form Ds with the SEC since 2022, most recently in Jul 2025 ($6.8 million sold to 19 investors).

CoreMap investors

12 investors are on record for CoreMap, including US National Science Foundation, Northpoint Capital Group, DRIVEN Accelerator Hub and Dudley Fund. The early-stage round in Jun 2026 drew 73 investors.

For fundraisers
Raising for a company like CoreMap?

12 investors have backed CoreMap.

See all 12 investors →

Frequently asked about CoreMap

How much has CoreMap raised?
CoreMap has raised $44.1M in total across 3 recorded funding rounds.
When was CoreMap's last funding round?
CoreMap's most recent recorded round was Early Stage VC in Jun 2026, raising $35.5M.